| 1/12/2021 |
What Could A Healthcare Marketplace Look Like? GoodRx Is Trying To Show Us |
Forbes |
... price and convenience. The company earns revenue only only when it saves people money. Thus far, the company estimates it has helped Americans realize $20 billion in savings.Doing good is going well for GoodRx and its investors, as suggested by the company’s $18 billion market capitalization (as of the publish date).While GoodRx’s growth has been impressive, it also begs questions:How does GoodRx save people money ... |
| 1/10/2021 |
Reviewing Clarivate (NYSE:CCC) and GoodRx (NASDAQ:GDRX) |
The Markets Daily |
N/AInsider and Institutional Ownership42.8% of Clarivate shares are owned by institutional investors. Comparatively, 13.2% of GoodRx shares are owned by institutional investors. 2.3% of Clarivate shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.SummaryClarivate beats GoodRx on 6 of the 10 factors compared between the ... |
| 1/10/2021 |
Comparing Clarivate (NYSE:CCC) and GoodRx (NASDAQ:GDRX) |
wkrb13.com |
Clarivate ( NYSE:CCC ) and GoodRx ( NASDAQ:GDRX ) are both large-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk and valuation.Earnings and ValuationGet Clarivate alerts: This table compares Clarivate and GoodRx’s revenue, earnings per share and valuation.Gross Revenue Price/Sales Ratio Net Income Earnings ... |
| 1/7/2021 |
GoodRx (NASDAQ:GDRX) and Clarivate (NYSE:CCC) Head to Head Analysis |
American Banking News |
GoodRx has lower revenue, but higher earnings than Clarivate.SummaryClarivate beats GoodRx on 6 of the 10 factors compared between the two stocks.Clarivate Company ProfileClarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne ... |
| 1/5/2021 |
Retire Better: How seniors are already falling behind in 202 |
MarketWatch |
... in 2021.Advocates said it wouldn’t be enough to keep up with the true cost of living , and just days into the new year, it looks like they were right.An analysis from GoodRx , a medical and health care services provider, calculates that 589 drugs—all but seven brand medications—now cost 4.2% more on average. That’s nearly three full percentage points more than the cost of living ... |
| 1/4/2021 |
Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 with nearly 600 price hikes |
FiercePharma |
... the level of many of the price hikes seems muted compared with previous years.As of Sunday, drug companies large and small had raised prices on nearly 600 medicines by an average of 4.2%, GoodRx reports .Pfizer's hikes comprise a significant portion of the list: The company raised prices on more than 130 products to start the year, ranging from a 0.22% jump for antiarrhythmic medicine Norpace CR to a ... |
| 1/1/2021 |
Could Medicare Help You Save on Expensive Asthma Inhalers? |
MSN |
... Box / Shutterstock.com Skyrocketing inhaler costs pose a financial barrier for many of the 25 million Americans with asthma . The average cash price inhalers increased from $280 in 2013 to $380 in 2018, according to GoodRx .Load ErrorIf you need an inhaler and are on Medicare, the federal health insurance program for seniors and people with certain disabilities , a little-known option may help you reduce your medication costs — ... |
| 12/29/2020 |
A look back at the how tech changed the pharma landscape in 2020 |
MobiHealthNews |
... 19 emergency. During this period we saw both Pear Therapeutics and Akili Interactive Labs take advantage of this early release. Another major area of interest this year was digital pharmacies. This year we saw GoodRx and Hims go public, signaling more consumer interest in the space. Read on for a list of highlights of digital pharma initiatives: Forging partnerships Kicking off the 2020 year, in Europe pharma giant Bayer inked ... |
| 12/29/2020 |
GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021 |
gurufocus.com |
Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against GoodRx Holdings, Inc. ("GoodRx" or "the Company") (NASDAQ: GDRX) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired GoodRx securities between September 23, 2020 to November 16, 2020, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site: [url="]www.bgandg.com ... |
| 12/29/2020 |
GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021 |
financialbuzz.com |
Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against GoodRx Holdings, Inc. (“GoodRx” or “the Company”) (NASDAQ: GDRX) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired GoodRx securities between September 23, 2020 to November 16, 2020, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s ... |
| 12/25/2020 |
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Has Been Filed Against GoodRx Holdings, and Encourages Investors to Contact the Firm Before February 16, 2021 |
financialbuzz.com |
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX ) securities during the period from September 23, 2020 through November 16, 2020 (the “Class Period”). Investors have until February 16, 2021 to apply to the ... |
| 12/24/2020 |
|
malvern-online.com |
The law firm of Kirby McInerney LLP announces that a has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX ) securities during the period from September 23, 2020 through November 16, 2020 (the “Class Period”). Investors have until February 16, 2021 to apply to the Court to be ... |
| 12/24/2020 |
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Has Been Filed Against GoodRx Holdings, Inc. and Encourages Investors to Contact the Firm Before February 16, 2021 |
Business Wire |
NEW YORK- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX ) securities during the period from September 23, 2020 through November 16, 2020 (the “Class Period”). Investors have until February 16, 2021 to apply ... |
| 12/24/2020 |
The Ridgway Record |
ridgwayrecord.com |
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX ) securities during the period from September 23, 2020 through November 16, 2020 (the “Class Period”). Investors have until February 16, 2021 to apply to the ... |
| 12/24/2020 |
Google Alert - marketing |
blogspot.com |
marketing As-it-happens update ⋅ December 24, 2020 NEWS Pet Palette Hires New Marketing Manager PetProductNews.com Limbeck has more than 10 years of marketing experience and is skilled at building a presence within the pet industry through strong branding, ... Flag as irrelevant WEB GoodRx - Inside Sales, Marketing Solution Lever Sales & Marketing – Operations /. Full Time. Apply for this job. At GoodRx , we believe that all Americans should have access ... |
| 12/24/2020 |
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Has Been Filed Against GoodRx Holdings, Inc. and Encourages Investors to Contact the Firm Before February 16, 2021 |
gurufocus.com |
The law firm of [url="]Kirby+McInerney+LLP[/url] announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: [url="]GDRX[/url]) securities during the period from September 23, 2020 through November 16, 2020 (the “Class Period”). Investors have until February 16, 2021 ... |
| 12/24/2020 |
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds GoodRx Holdings, Inc. Investors of Important Deadline in Securities Class Action GDRX |
financialbuzz.com |
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 to November 16, 2020, inclusive (the “Class Period”) of the important February 16, 2021 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for GoodRx investors under the federal securities laws.To join the GoodRx class action, go to http://www.rosenlegal.com/cases ... |
| 12/23/2020 |
Is GoodRx Stock A Buy? |
financhill.com |
Is GoodRx Stock A Buy? - Financhill Menu Investing Is GoodRx Stock A Buy?Is GoodRx Stock A Buy? Telemedicine’s rising popularity has been spurred by the global pandemic. Talk about a sizzling investment space! For instance, consider Teladoc ( TDOC ) – the company’s stock has skyrocketed by almost 170% in 2020.While patients and their physicians adapt to a virtual world of interactions, the healthcare industry is desperately seeking ... |
| 12/23/2020 |
The Ridgway Record |
ridgwayrecord.com |
NEW YORK, Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against GoodRx Holdings, Inc. ("GoodRx" or "the Company") ( NASDAQ: GDRX ) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired GoodRx securities between September 23, 2020 to November 16, 2020, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm ... |
| 12/23/2020 |
Is GoodRx Stock A Buy? |
blogspot.com |
Is GoodRx Stock A Buy? Telemedicine's rising popularity has been spurred by the global pandemic. Talk about a sizzling investment space! For instance, consider Market News Smart Trading. Simplified. Is this Killer new EXTRA INCOME strategy the Best Side Hustle EVER? Have you seen this new extra-income hack yet?Everyday Americans have been making 100%, 200%, 500%, or more... sometimes in a matter of days with this one new ... |